COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 1655: Articles 16541-16550  | Next

Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees
Deal, A., Hayward, S. E., Huda, M., Knights, F., Crawshaw, A. F., Carter, J., Hassan, O. B., Farah, Y., Ciftci, Y., Rowland-Pomp, M., Rustage, K., Goldsmith, L., Hartmann, M., Mounier-Jack, S., Burns, R., Miller, A., Wurie, F., Campos-Matos, I., Majeed, A., Hargreaves, S.
10.1101/2021.04.12.21255313 — Posted: 2021-04-19
Comparison of preprints and final journal publications from COVID-19 Studies: Discrepancies in results reporting and spin in interpretation
Bero, L., Lawrence, R., Leslie, L., Chiu, K., McDonald, S., Page, M., Grundy, Q., Parker, L., Boughton, S., Kirkham, J., Featherstone, R.
10.1101/2021.04.12.21255329 — Posted: 2021-04-19
The impact of population mobility on COVID-19 incidence and socioeconomic disparities at the sub-city level in 314 Latin American cities
Kephart, J. L., Delclos-Alio, X., Bilal, U., Sarmiento, O. L., Barrientos-Gutierrez, T., Ramirez-Zea, M., Quistberg, D. A., Rodriguez, D. A., Diez Roux, A. V.
10.1101/2021.04.13.21255413 — Posted: 2021-04-19
Outcomes of COVID-19 infection in patients treated with Clozapine.
Govind, R., Fonseca de Freitas, D., Pritchard, M., Khondoker, M., Teo, J. T., Stewart, R., Hayes, R. D., MacCabe, J. H.
10.1101/2021.04.13.21255384 — Posted: 2021-04-19
The multi-dimensional challenges of controlling SARS-CoV-2 transmission in indoor spaces: Insights from the linkage of a microscopic pedestrian simulation and virus transmission models
Duives, D., Chang, Y., Sparnaaij, M., Wouda, B., Boschma, D., Liu, Y., Yuan, Y., Daamen, W., de Jong, M. C. M., Teberg, C., Schachtschneider, K., Sikkema, R. S., van Veen, L., ten Bosch, Q.
10.1101/2021.04.12.21255349 — Posted: 2021-04-19
Assessing the impact of SARS-CoV-2 prevention measures in schools by means of agent-based simulations calibrated to cluster tracing data
Lasser, J., Sorger, J., Richter, L., Thurner, S., Schmid, D., Klimek, P.
10.1101/2021.04.13.21255320 — Posted: 2021-04-19
The effect of population mobility restrictive measures on the incidence of SARS-CoV-2 infection in the early phase of the pandemic
Modelli de Andrade, L. G., Ferreira, G. F., Tedesco Silva, H.
10.1101/2021.04.13.21255382 — Posted: 2021-04-19
SARS-CoV-2 transmission dynamics in Belarus revealed by genomic and incidence data analysis
Nemira, A., Adeniyi, A. E., Gasich, E., Bulda, K., Valentovich, L., Krasko, A., Kirpich, A., Skums, P.
10.1101/2021.04.13.21255404 — Posted: 2021-04-19
Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection
Dowell, A. C., Butler, M. S., Jinks, E., Tut, G., Lancaster, T., Sylla, P., Begum, J., Spalkova, E., Davies, S., Pearce, H., Taylor, G. S., Syrimi, E., Baawuah, F., BECKMANN, J., OKIKE, I., Ahmad, S., GARSTANG, J., Brent, A., Brent, B., Ireland, G., Aiano, F., Amin-Chowdhury, Z., Jones, S., Borrow, R., Linley, E., Poh, J., Saliba, V., Amirthalingam, G., Brown, K., Ramsay, M., Zuo, J., Moss, P., Ladhani, S.
10.1101/2021.04.12.21255275 — Posted: 2021-04-19
Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation
Al-Jaf, S. M. A., Niranji, S. S., Mahmood, Z. H.
10.1101/2021.04.12.21255337 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).